Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: LMA Proseal
Total 0 results
Nothing found
Sponsors and Collaborators
Kupfer, David J., M.D.
Neurophth Therapeutics Inc
Korean Society of Spine Surgery
Aptis Medical
Hospital ASEPEYO Sant Cugat
GFI
Alma Lasers Inc.
Principal Investigator Mohanad Omar Ahmed, Msc Pharmacy Practice Department- Horus University
Mª Victoria Maestre Sanchez
ASST Cremona, Cremona
Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.
RMIT University, Melbourne, Australia
Hospital Durand, Argentina
Apollo Neuroscience, Inc.
iCAD
Agency for Science, Technology and Research
Jiande Branch, Second Affiliated Hospital, School of Medicine, Zhejiang University
Nacuity Pharmaceuticals, Inc.
Eurofins Genoma
Everett Meyer
View Full List
Medical Conditions
Rheumatoid Arthritis(RA)
STAGE IIIA/B NSCLC / INOPERABLE LUNG CANCER
Recurrent Clear Cell Sarcoma of Soft Tissue
Luteal Phase Support
Disorder of Fluid Balance
The Strength Properties of the Aorta in Vitro
Major Liver Surgery
RISS Stage III Plasma Cell Myeloma
Immune-Mediated Inflammatory Disease
Treatment Decisions
Corneal Cross-Linking
Dienogest
Splenic Trauma
Scleredema
T-LGL Leukemia
Metachronous Adenoma
Fever
24 Hours Esophageal PH and Multichannel Intraluminal Impedance Testing
Chronic Constipation Symptoms
Gastric Cancer Stage IIIB-IIIC
View Full List
Drug Interventions
TPN-101
MLN2480
Intravenous deferiprone
Camptosar
Capecitabine/cisplatin
THC
Fospropofol disodium, propofol
GLPG1837 multiple ascending doses
Standard of care (SOC) for COVID-19
OnabotulinumtoxinA
RDX227675
Intravenous Formulation of PD-0332991
PD-1/PD-L1 inhibitor
Olopatadine
Midazolam
Desvenlafaxine
Anticholinergic
Capecitabine and IMRT (if randomized to this arm)
Oxycodone/acetaminophen 5/325 mg
Letrozole
View Full List
CROs by country
Contract Research Organizations in Argentina
Contract Research Organizations in Cameroon
Contract Research Organizations in Chile
Contract Research Organizations in Congo, DR of
Contract Research Organizations in Costa Rica
Contract Research Organizations in Gabon
Contract Research Organizations in Ireland
Contract Research Organizations in Jordan
Contract Research Organizations in Kazakhstan
Contract Research Organizations in Kyrgyzstan
Contract Research Organizations in Mongolia
Contract Research Organizations in Panama
Contract Research Organizations in Suriname
CRO list by country
CROs in Bahrain
SGS
All CROs in Bahrain
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe